Jill Hood

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study

Casey Cunningham, Sunil Chada, James A. Merritt et al. · Molecular Therapy · 2004 · 210 citations

Medicine, Oncology, Pharmacology +15

Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer Patients

Alex W. Tong, John Nemunaitis, Dan Su et al. · Molecular Therapy · 2004 · 200 citations · Full text

Medicine, Cancer Biology, Oncology +13

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev et al. · Journal for ImmunoTherapy of Cancer · 2020 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

Infilling missing precipitation records using variants of spatial interpolation and data‐driven methods: use of optimal weighting parameters and nearest neighbour‐based corrections

Ramesh S. V. Teegavarapu, Alaa H. Aly, Chandra S. Pathak et al. · International Journal of Climatology · 2017 · 57 citations

Computing, Hydrology, Meteorology +16

Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type <i>p53</i> Gene, in Patients With Advanced Cancer

Anthony W. Tolcher, Desirée Hao, Johann S. de Bono et al. · Journal of Clinical Oncology · 2006 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17